...
pstv-img

Plus Therapeutics Inc, Common Stock

PSTV

NAQ

$1.07

-$0.02

(-1.83%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.43M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
40.98K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.69
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.93 L
$2.67 H
$1.07

About Plus Therapeutics Inc, Common Stock

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePSTVSectorS&P500
1-Week Return-8.55%-0.94%-2.6%
1-Month Return-13.01%-5.08%-1.08%
3-Month Return-32.7%-10.62%3.45%
6-Month Return-33.13%-6.18%8.57%
1-Year Return-43.68%1.98%24.3%
3-Year Return-93.95%-0.93%25.58%
5-Year Return-97.09%33.84%84.07%
10-Year Return-100%102.52%185.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue7.00M303.00K-224.00K4.91M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":4.33,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":3.2,"profit":true},{"date":"2023-12-31","value":70.21,"profit":true}]
Cost of Revenue5.37M2.70M66.00K712.00K9.69M[{"date":"2019-12-31","value":55.37,"profit":true},{"date":"2020-12-31","value":27.86,"profit":true},{"date":"2021-12-31","value":0.68,"profit":true},{"date":"2022-12-31","value":7.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit1.63M(2.40M)(66.00K)(488.00K)(4.78M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-146.79,"profit":false},{"date":"2021-12-31","value":-4.04,"profit":false},{"date":"2022-12-31","value":-29.88,"profit":false},{"date":"2023-12-31","value":-292.53,"profit":false}]
Gross Margin23.34%(791.09%)(Infinity%)(217.86%)(97.23%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-3390.11,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":-933.6,"profit":false},{"date":"2023-12-31","value":-416.67,"profit":false}]
Operating Expenses10.65M9.89M12.43M19.94M8.54M[{"date":"2019-12-31","value":53.45,"profit":true},{"date":"2020-12-31","value":49.59,"profit":true},{"date":"2021-12-31","value":62.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.86,"profit":true}]
Operating Income(3.66M)(9.58M)(12.49M)(19.71M)(13.32M)[{"date":"2019-12-31","value":-365700000,"profit":false},{"date":"2020-12-31","value":-958400000,"profit":false},{"date":"2021-12-31","value":-1249200000,"profit":false},{"date":"2022-12-31","value":-1971200000,"profit":false},{"date":"2023-12-31","value":-1332100000,"profit":false}]
Total Non-Operating Income/Expense(1.43M)286.00K(1.82M)(1.13M)10.00K[{"date":"2019-12-31","value":-498.6,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-636.36,"profit":false},{"date":"2022-12-31","value":-394.06,"profit":false},{"date":"2023-12-31","value":3.5,"profit":true}]
Pre-Tax Income(3.28M)(8.24M)(13.40M)(20.27M)(13.32M)[{"date":"2019-12-31","value":-328300000,"profit":false},{"date":"2020-12-31","value":-824100000,"profit":false},{"date":"2021-12-31","value":-1339900000,"profit":false},{"date":"2022-12-31","value":-2027500000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false}]
Income Taxes9.46M1.11M932.00K563.00K-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":11.7,"profit":true},{"date":"2021-12-31","value":9.85,"profit":true},{"date":"2022-12-31","value":5.95,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(12.74M)(9.35M)(14.33M)(20.84M)-[{"date":"2019-12-31","value":-1274200000,"profit":false},{"date":"2020-12-31","value":-934800000,"profit":false},{"date":"2021-12-31","value":-1433100000,"profit":false},{"date":"2022-12-31","value":-2083800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(3.28M)(8.24M)(13.40M)(20.27M)(13.32M)[{"date":"2019-12-31","value":-328300000,"profit":false},{"date":"2020-12-31","value":-824100000,"profit":false},{"date":"2021-12-31","value":-1339900000,"profit":false},{"date":"2022-12-31","value":-2027500000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false}]
Income From Discontinued Operations(7.60M)----[{"date":"2019-12-31","value":-760400000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(12.74M)(9.35M)(14.33M)(20.84M)(13.32M)[{"date":"2019-12-31","value":-1274200000,"profit":false},{"date":"2020-12-31","value":-934800000,"profit":false},{"date":"2021-12-31","value":-1433100000,"profit":false},{"date":"2022-12-31","value":-2083800000,"profit":false},{"date":"2023-12-31","value":-1331600000,"profit":false}]
EPS (Diluted)(13.92)(1.60)(1.13)(0.84)(2.57)[{"date":"2019-12-31","value":-1392,"profit":false},{"date":"2020-12-31","value":-160,"profit":false},{"date":"2021-12-31","value":-113,"profit":false},{"date":"2022-12-31","value":-84,"profit":false},{"date":"2023-12-31","value":-257,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PSTV
Cash Ratio 0.40
Current Ratio 0.44

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PSTV
ROA (LTM) -69.39%
ROE (LTM) -522.50%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PSTV
Debt Ratio Lower is generally better. Negative is bad. 1.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.74

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PSTV
Trailing PE NM
Forward PE NM
P/S (TTM) 1.15
P/B 3.76
Price/FCF NM
EV/R 18.19
EV/Ebitda NM

FAQs

What is Plus Therapeutics Inc share price today?

Plus Therapeutics Inc (PSTV) share price today is $1.07

Can Indians buy Plus Therapeutics Inc shares?

Yes, Indians can buy shares of Plus Therapeutics Inc (PSTV) on Vested. To buy Plus Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PSTV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Plus Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Plus Therapeutics Inc (PSTV) via the Vested app. You can start investing in Plus Therapeutics Inc (PSTV) with a minimum investment of $1.

How to invest in Plus Therapeutics Inc shares from India?

You can invest in shares of Plus Therapeutics Inc (PSTV) via Vested in three simple steps:

  • Click on Sign Up or Invest in PSTV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Plus Therapeutics Inc shares
What is Plus Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Plus Therapeutics Inc (PSTV) is $2.67. The 52-week low price of Plus Therapeutics Inc (PSTV) is $0.93.

What is Plus Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Plus Therapeutics Inc (PSTV) is

What is Plus Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Plus Therapeutics Inc (PSTV) is 3.76

What is Plus Therapeutics Inc dividend yield?

The dividend yield of Plus Therapeutics Inc (PSTV) is 0.00%

What is the Market Cap of Plus Therapeutics Inc?

The market capitalization of Plus Therapeutics Inc (PSTV) is $6.43M

What is Plus Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Plus Therapeutics Inc is PSTV

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top